QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: How EU Marketing Authorisation Decisions Are Implemented and Maintained After Approval

Test your understanding of the concepts covered by How EU Marketing Authorisation Decisions Are Implemented and Maintained After Approval.

Question 1 of 10Pass mark: 80%

Question 1 of 10 What is the most appropriate interpretation of the QPPV's role in relation to the marketing authorisation lifecycle?

The QPPV personally owns every regulatory submission and implementation task. The QPPV has no responsibility until a safety referral is initiated. The QPPV oversees the pharmacovigilance system and must have sufficient awareness of material regulatory changes affecting PV obligations. The QPPV replaces Regulatory Affairs as the owner of the marketing authorisation.

Question 2 of 10 Which organisational arrangement best supports effective lifecycle governance?

Regulatory Affairs performs all implementation tasks without involving other functions. The QPPV owns every regulatory and operational activity. Functions retain defined responsibilities while explicit interfaces ensure that regulatory changes reach PV, quality, labelling and other affected areas. Each local affiliate independently determines the applicable EU regulatory baseline.

Question 3 of 10 Why is the regulatory effectiveness date important when assessing whether a contraindication applied to a patient case occurring several years ago?

It identifies when the commercial team first communicated the change. It determines which regulatory baseline and product-information version were legally applicable at the relevant time. It establishes when the safety issue was first detected internally. It replaces the need to retain superseded product-information versions.

Question 4 of 10 Which activity most clearly represents implementation of an authorised safety change?

Recording an internal recommendation to update a warning. Submitting proposed wording to the competent authority. Updating controlled product information and relevant downstream systems after the change becomes effective. Discussing the potential change during a safety governance meeting.

Question 5 of 10 Why is it insufficient to mark a post-authorisation commitment as complete solely because the company finished its internal activity?

Internal activity is never relevant to regulatory commitments. Some commitments require confirmation or formal closure by the relevant authority. Only the QPPV can close any commitment. Completion can be established only through commercial performance.

Question 6 of 10 What is the principal governance risk when the interface between Regulatory Affairs and Pharmacovigilance is weak?

The product will necessarily lose its marketing authorisation immediately. A regulatory decision may be legally correct but fail to be reflected accurately in the PV system and related processes. Commercial forecasts will automatically become invalid. All safety reports will be considered counterfeit.

Question 7 of 10 What is the purpose of a regulatory commitment register?

To replace the formal marketing authorisation. To track the source, owner, milestones, status, evidence and, where relevant, regulatory closure of ongoing obligations. To record only completed internal training. To document commercial sales targets associated with the product.

Question 8 of 10 Why can a current product-information document be insufficient evidence for a historical pharmacovigilance review?

Product information has no regulatory significance. The current document may contain changes that were not legally effective during the historical period being assessed. Historical reviews require only internal company documents. Current documents cannot be used for any regulatory purpose.

Question 9 of 10 Which combination best reflects the information needed to maintain reliable regulatory lifecycle traceability?

Approval announcement, sales forecast and current promotional plan. Internal safety conclusion, meeting minutes and training attendance only. Regulatory source, effective date, authorised document version, implementation evidence and superseded history. Commercial discontinuation date, inventory level and affiliate communication.

Question 10 of 10 Which statement most accurately distinguishes suspension, revocation and withdrawal?

They are interchangeable terms for any temporary product interruption. Suspension generally restricts the authorisation, revocation terminates it under the applicable legal mechanism, and withdrawal may have different effects depending on its legal basis. Suspension is always voluntary, while withdrawal is always imposed by an authority. Revocation affects only product information and not the authorisation.

Knowledge Assessment: How EU Marketing Authorisation Decisions Are Implemented and Maintained After Approval

Cookie Settings